Gene · 1056
Papers4,548
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,548
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The biomarkers' landscape of post-COVID-19 patients can suggest selective clinical interventions. | Sci Rep | 2023 | 38110483 | PubTator, text mining | PubMed |
| Mechanisms Behind the Pharmacological Application of Biochanin-A: A review. | F1000Res | 2023 | 38106650 | PubTator, text mining | PubMed |
| Tailoring tumor-recognizable hyaluronic acid-lipid conjugates to enhance anticancer efficacies of surface-engineered natural killer cells. | Nano Converg | 2023 | 38097911 | PubTator, text mining | PubMed |
| Comparison of two RT-qPCR methods targeting BK polyomavirus microRNAs in kidney transplant recipients. | Front Med (Lausanne) | 2023 | 38093979 | PubTator, text mining | PubMed |
| miR-6805-5p as a biomarker of cisplatin-induced nephrotoxicity in patients with head and neck cancer. | Front Pharmacol | 2023 | 38089043 | PubTator, text mining | PubMed |
| Hypochlorous acid hygiene solution in patients affected by blepharitis: a prospective randomised study. | BMJ Open Ophthalmol | 2023 | 38088255 | PubTator, text mining | PubMed |
| Association Between ALDH2 Polymorphisms and the Risk of Diabetes Mellitus in Hypertensive Patients. | Int J Gen Med | 2023 | 38084269 | PubTator, text mining | PubMed |
| A positive feedback loop between ZEB2 and ACSL4 regulates lipid metabolism to promote breast cancer metastasis. | Elife | 2023 | 38078907 | PubTator, text mining | PubMed |
| Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes. | Front Endocrinol (Lausanne) | 2023 | 38075070 | PubTator, text mining | PubMed |
| Construction of a prognostic 6-gene signature for breast cancer based on multi-omics and single-cell data. | Front Oncol | 2023 | 38074669 | PubTator, text mining | PubMed |
| Drug product attributes predict clinical efficacy in betibeglogene autotemcel gene therapy for β-thalassemia. | Mol Ther Methods Clin Dev | 2023 | 38074412 | PubTator, text mining | PubMed |
| Molecular Signatures Integral to Natural Reprogramming in the Pigment Epithelium Cells after Retinal Detachment in Pleurodeles waltl. | Int J Mol Sci | 2023 | 38069262 | PubTator, text mining | PubMed |
| miR-877-5p as a Potential Link between Triple-Negative Breast Cancer Development and Metabolic Syndrome. | Int J Mol Sci | 2023 | 38069080 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Factors in Gestational Diabetes Mellitus Pathology. | Int J Mol Sci | 2023 | 38068941 | PubTator, text mining | PubMed |
| Can We Improve Diosmetin Activity? The State-of-the-Art and Promising Research Directions. | Molecules | 2023 | 38067639 | PubTator, text mining | PubMed |
| Solid Lipid Nanoparticles Containing Dopamine and Grape Seed Extract: Freeze-Drying with Cryoprotection as a Formulation Strategy to Achieve Nasal Powders. | Molecules | 2023 | 38067437 | PubTator, text mining | PubMed |
| Secreted miR-210-3p, miR-183-5p and miR-96-5p reduce sensitivity to docetaxel in prostate cancer cells. | Cell Death Discov | 2023 | 38065937 | PubTator, text mining | PubMed |
| Impact of three miRNA signature as potential diagnostic marker for triple negative breast cancer patients. | Sci Rep | 2023 | 38062163 | PubTator, text mining | PubMed |
| Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity. | Signal Transduct Target Ther | 2023 | 38062078 | PubTator, text mining | PubMed |
| Association between opioid abuse and COVID-19 susceptibility: a propensity score matched study. | BMC Infect Dis | 2023 | 38053042 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1056/papers?page=12